CGON
Price
$27.45
Change
+$0.63 (+2.35%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
2.04B
77 days until earnings call
ZURA
Price
$2.02
Change
-$0.02 (-0.98%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
132.64M
Interact to see
Advertisement

CGON vs ZURA

Header iconCGON vs ZURA Comparison
Open Charts CGON vs ZURABanner chart's image
CG Oncology
Price$27.45
Change+$0.63 (+2.35%)
Volume$12.15K
Capitalization2.04B
Zura Bio
Price$2.02
Change-$0.02 (-0.98%)
Volume$3.73K
Capitalization132.64M
CGON vs ZURA Comparison Chart in %
Loading...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGON vs. ZURA commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a StrongBuy and ZURA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (CGON: $26.82 vs. ZURA: $2.04)
Brand notoriety: CGON and ZURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 54% vs. ZURA: 24%
Market capitalization -- CGON: $2.04B vs. ZURA: $132.64M
CGON [@Biotechnology] is valued at $2.04B. ZURA’s [@Biotechnology] market capitalization is $132.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileZURA’s FA Score has 1 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • ZURA’s FA Score: 1 green, 4 red.
According to our system of comparison, ZURA is a better buy in the long-term than CGON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 6 TA indicator(s) are bullish while ZURA’s TA Score has 4 bullish TA indicator(s).

  • CGON’s TA Score: 6 bullish, 3 bearish.
  • ZURA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CGON is a better buy in the short-term than ZURA.

Price Growth

CGON (@Biotechnology) experienced а -0.35% price change this week, while ZURA (@Biotechnology) price change was +1.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Reported Earning Dates

CGON is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGON($2.05B) has a higher market cap than ZURA($133M). CGON YTD gains are higher at: -6.485 vs. ZURA (-18.400). ZURA has higher annual earnings (EBITDA): -72.34M vs. CGON (-157.09M). CGON has more cash in the bank: 661M vs. ZURA (154M). CGON has higher revenues than ZURA: CGON (551K) vs ZURA (0).
CGONZURACGON / ZURA
Capitalization2.05B133M1,538%
EBITDA-157.09M-72.34M217%
Gain YTD-6.485-18.40035%
P/E RatioN/A7.96-
Revenue551K0-
Total Cash661M154M429%
Total Debt994KN/A-
TECHNICAL ANALYSIS
Technical Analysis
CGONZURA
RSI
ODDS (%)
N/A
Bearish Trend 5 days ago
44%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
59%
Momentum
ODDS (%)
Bullish Trend 5 days ago
74%
Bullish Trend 5 days ago
60%
MACD
ODDS (%)
Bullish Trend 5 days ago
74%
Bullish Trend 5 days ago
58%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
82%
Bullish Trend 5 days ago
47%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
82%
Bullish Trend 5 days ago
46%
Advances
ODDS (%)
Bullish Trend 5 days ago
73%
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
Bearish Trend 14 days ago
83%
Bearish Trend 5 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
89%
Bearish Trend 5 days ago
49%
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
41%
View a ticker or compare two or three
Interact to see
Advertisement
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TIBCX31.22-0.02
-0.06%
Thornburg Investment Income Builder C
CDEYX18.36-0.03
-0.16%
Columbia Intrinsic Value Institutional 3
PLBBX39.72-0.15
-0.38%
Plumb Balanced Investor
PIGRX16.89-0.12
-0.71%
Putnam International Value C
LIESX21.24-0.17
-0.79%
Franklin International Equity IS

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with SYRE. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
+0.39%
SYRE - CGON
60%
Loosely correlated
-1.38%
IDYA - CGON
60%
Loosely correlated
-1.52%
KYMR - CGON
56%
Loosely correlated
-1.32%
ACLX - CGON
55%
Loosely correlated
-1.22%
NUVL - CGON
55%
Loosely correlated
+0.74%
More

ZURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZURA has been loosely correlated with SYRE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ZURA jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZURA
1D Price
Change %
ZURA100%
-3.77%
SYRE - ZURA
44%
Loosely correlated
-1.38%
CGON - ZURA
42%
Loosely correlated
+0.39%
CRNX - ZURA
40%
Loosely correlated
+1.11%
BIESF - ZURA
40%
Loosely correlated
N/A
CCCC - ZURA
39%
Loosely correlated
+1.96%
More